We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
RPS Appoints Mark D. Myslinski Chief Executive Officer
News

RPS Appoints Mark D. Myslinski Chief Executive Officer

RPS Appoints Mark D. Myslinski Chief Executive Officer
News

RPS Appoints Mark D. Myslinski Chief Executive Officer

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "RPS Appoints Mark D. Myslinski Chief Executive Officer"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Before joining RPS, Myslinski has held positions as Senior Vice President and General Manager, Diagnostics of Hologic, Inc. Prior to that, Myslinski was President and CEO of RedPath Integrated Pathology, Inc. He has also successfully led Veridex LLC, a subsidiary of Johnson & Johnson’s Ortho-Clinical Diagnostics, as General Manager where the team pioneered the clinical use of circulating tumor cells.

“Mark brings a wealth of knowledge and valuable point of care diagnostic experience to RPS,” said Robert Sambursky MD, President, Chief Medical Officer, and Executive Chairman of RPS. “His diverse background and strong leadership skills will accelerate our growth as a leader in the development of novel and rapid in-office tests for infectious and inflammatory diseases.”

Myslinski stated, “I am thrilled to lead this team to further leverage the RPS platform to improve the speed and accuracy of diagnoses and, importantly, to drive down health care costs. The point-of-care market is growing rapidly and RPS has developed a first-of-its-kind platform that can disrupt some diagnostic algorithms, bringing more rapid and accurate results to the point of care. This innovative platform more quickly empowers health care providers with evidence to aid them in making informed treatment decisions.”

Myslinski earned his BA in Economics from Moravian College and his MBA from Ohio University. He is also an active member of the Board of Directors of two diagnostics companies.

Advertisement